Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sulphonamides Market
Sulphonamides Market Size
- Report ID: GMI9708
- Published Date: May 2024
- Report Format: PDF
Sulphonamides Market Size
Sulphonamides Market was valued at USD 122.4 million in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032, driven by the increasing prevalence of infectious diseases globally. Furthermore, the increasing awareness among healthcare providers and patients about the effectiveness of sulphonamides is contributing to their higher prescription rates, thereby further expanding the market growth.
Sulphonamide treatment involves the use of medications from the sulphonamide group, which are synthetic antimicrobial agents. These drugs inhibit the growth and multiplication of bacteria by acting as competitive inhibitors of the enzyme dihydropteroate synthase involved in folate synthesis. Sulphonamides are bacteriostatic, meaning they inhibit bacterial growth without killing the bacteria. They are commonly used to treat bacterial infections, UTIs, and other conditions.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Sulphonamides Market Size in 2023: | USD 122.4 Million |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 4.8% |
| 2032 Value Projection: | USD 184.4 Million |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 242 |
| Tables, Charts & Figures: | 259 |
| Segments covered: | Route of Administration, Application, Medication Type, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Sulphonamides Market Scope
